Egetis Therapeutics AB (publ) (STO:EGTX)
Sweden
· Delayed Price · Currency is SEK 5.81
+0.02 (0.35%)
Apr 29, 2026, 10:49 AM CET
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 2.29 billion as of April 28, 2026. Its market cap has increased by 57.65% in one year.
Market Cap
2.29B
Enterprise Value
2.16B
Revenue
62.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.81
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 224.89M to 2.29B, an increase of 917.38%. That is a compound annual growth rate of 16.65%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 2.29B |
| Hansa Biopharma AB | 2.55B |
| Saniona AB | 1.97B |
| Vicore Pharma Holding AB | 2.86B |
| BioInvent International AB | 1.45B |
| Genovis AB (publ.) | 1.32B |
| Xspray Pharma AB | 1.13B |
| Medivir AB | 1.04B |